(Q46797948)

25 December 2017

title

Progress in the treatment of childhood brain tumors: no room for complacency (English)

1 reference

25 December 2017

1 reference

Jonathan L Finlay

1

1 reference

25 December 2017

Anat Erdreich-Epstein

series ordinal

2

1 reference

25 December 2017

Roger J Packer

series ordinal

3

1 reference

25 December 2017

publication date

1 January 2007

1 reference

25 December 2017

Pediatric Hematology and Oncology

published in

1 reference

25 December 2017

volume

24

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

79-84

1 reference

25 December 2017

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Medulloblastoma: signalling a change in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Molecular biology of medulloblastoma: will it ever make a difference to clinical management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Molecularly targeted therapy for pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Anti-angiogenic therapy in pediatric neuro-oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08880010601001073

10.1080/08880010601001073

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017